Capricor Therapeutics Inc (CAPR) Stock: Navigating a Year of Stock Volatility

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Capricor Therapeutics Inc’s current trading price is -56.88% away from its 52-week high, while its distance from the 52-week low is 186.65%. The stock’s price range for this period has been between $3.52 and $23.40 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.31 million for the day, a number notably lower than the average daily volume of 2.1 million over the last three months.

Capricor Therapeutics Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $23.40 on 10/15/24 and the lowest value was $3.52 on 08/07/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Capricor Therapeutics Inc (CAPR) has experienced a quarterly decline of -29.83% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 461.19M and boasts a workforce of 160 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 12.33, with a change in price of -4.87. Similarly, Capricor Therapeutics Inc recorded 1,649,843 in trading volume during the last 100 days, posting a change of -32.55%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for CAPR stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.03.

CAPR Stock Stochastic Average

As of today, Capricor Therapeutics Inc’s raw stochastic average for the last 50 days stands at 45.05%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 54.96%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 59.52% and 58.86%, respectively.

CAPR Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Year to date metric has recorded a loss of -26.88%.However, over the last six months, we can see a stronger performance of -45.81%. Over the last 30 days, the price of CAPR has leaped by -19.67%. And in the last five days, it has fallen by -9.26%.

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.